MYCAMINE 50 mg, powder for concentrate for infusion bottle, 10 ml
Active ingredients: Micafungin, Micafungin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for concentrate for infusionbottle, 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MYCAMINE 50 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- SANDOZ PHARMACEUTICALS (SLOVENIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63197760CIP73866272CIP133400938662726Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MICAFUNGINEpoudre | 50 mg · un flacon | FT |
| MICAFUNGINE SODIQUEpoudre | 50,86 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.